Page last updated: 2024-12-07

5-methyltryptophan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Methyltryptophan, also known as 5-HTP, is a naturally occurring amino acid that serves as a precursor to serotonin. It is found in various plant sources, including Griffonia simplicifolia seeds. 5-Methyltryptophan is synthesized from tryptophan through the action of the enzyme tryptophan hydroxylase. It is primarily studied for its potential therapeutic benefits in treating conditions related to serotonin deficiency, such as depression, anxiety, and insomnia. 5-Methyltryptophan is known to cross the blood-brain barrier and increase serotonin levels in the brain, contributing to its mood-regulating effects. Research indicates that 5-Methyltryptophan may also have potential applications in managing migraines, fibromyalgia, and premenstrual syndrome. However, it's crucial to note that 5-Methyltryptophan should be used with caution and under the guidance of a healthcare professional as it can interact with certain medications and may cause adverse effects. '

5-methyltryptophan: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-methyltryptophan : A tryptophan derivative that is tryptophan substituted by a methyl group at position 5 of the indole ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92852
CHEMBL ID569600
CHEBI ID52524
SCHEMBL ID41267
SCHEMBL ID18029004
MeSH IDM0045159

Synonyms (32)

Synonym
nsc57695
nsc-57695
951-55-3
5-methyltryptophan
M-5024
5-methyl-dl-tryptophan ,
CHEBI:52524 ,
CHEMBL569600
AKOS003382639
M0452
h-dl-trp(5-me)-oh
2-amino-3-(5-methyl-1h-indol-3-yl)propanoic acid
(2r)-2-azaniumyl-3-(5-methyl-1h-indol-3-yl)propanoate
tryptophan, 5-methyl-, dl-
einecs 213-453-6
5-methyl tryptophan, dl-
dl-5-methyltryptophan
nsc 57695
5-methyl-tryptophan
FT-0620650
SCHEMBL41267
SCHEMBL18029004
dl-tryptophan, 5-methyl-
5-methyltryptophan #
mfcd00005652
5-methyl-dl-tryptophan (h-dl-trp(5-me)-oh)
CS-D0272
Q27123483
CS-15061
h-trp(5-me)-oh
DTXSID001314252
dl-2-amino-3-(5-methylindolyl) propionic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The effect is observable with both stationary-phase and log-phase populations, but is not observable when a relatively high dosage of ultraviolet light is employed."( "Mutational synergism" of ultraviolet light and caffeine in Escherichia coli.
SHANKEL, DM, 1962
)
0.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
tryptophan derivativeAn amino acid derivative resulting from reaction of tryptophan at the amino group or the carboxy group, or from the replacement of any hydrogen of tryptophan by a heteroatom. The definition normally excludes peptides containing tryptophan residues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID422792Activity at 1.62 uM Aspergillus fumigatus CdpNPT assessed as compound conversion rate at 1 mM after 16 hrs by HPLC analysis in presence of dimethylallyl diphosphate relative to L-tryptophan2009Journal of natural products, Jan, Volume: 72, Issue:1
Substrate promiscuity of the cyclic dipeptide prenyltransferases from Aspergillus fumigatus ( section sign).
AID422790Activity at 1.62 uM Aspergillus fumigatus CdpNPT assessed as compound conversion rate at 1 mM after 2 hrs by HPLC analysis in presence of dimethylallyl diphosphate relative to L-tryptophan2009Journal of natural products, Jan, Volume: 72, Issue:1
Substrate promiscuity of the cyclic dipeptide prenyltransferases from Aspergillus fumigatus ( section sign).
AID422795Activity at 1.68 uM Aspergillus fumigatus FtmPT1 assessed as compound conversion rate at 1 mM after 16 hrs by HPLC analysis in presence of dimethylallyl diphosphate relative to L-tryptophan2009Journal of natural products, Jan, Volume: 72, Issue:1
Substrate promiscuity of the cyclic dipeptide prenyltransferases from Aspergillus fumigatus ( section sign).
AID422794Activity at 1.68 uM Aspergillus fumigatus FtmPT1 assessed as compound conversion rate at 1 mM after 2 hrs by HPLC analysis in presence of dimethylallyl diphosphate relative to L-tryptophan2009Journal of natural products, Jan, Volume: 72, Issue:1
Substrate promiscuity of the cyclic dipeptide prenyltransferases from Aspergillus fumigatus ( section sign).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (36.36)18.7374
1990's9 (20.45)18.2507
2000's12 (27.27)29.6817
2010's7 (15.91)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.51 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]